eFFECTOR Therapeutics Earnings Estimates, EPS & Revenue | OTC:EFTR

Comments

eFFECTOR Therapeutics Inc Earnings Estimates

EFTROTCEM

Trade with Public

$0.1800

-0.0869-32.56%

At close: Jul 1, 5:00 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest

eFFECTOR Therapeutics Earnings Estimates, EPS & Revenue | OTC:EFTR

In the most recent quarter (Q1), eFFECTOR Therapeutics reported EPS of $-2.16, meeting estimates of $-2.16. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, eFFECTOR Therapeutics has averaged an EPS surprise of 0.33% and a revenue surprise of 0.00%.

Earnings Date

May 9

EPS

$-2.160

Quarterly Revenue

$0.00

Annual Revenue
(as of Mar 31)

–

eFFECTOR Therapeutics Earnings History

Analyze the earnings history of eFFECTOR Therapeutics using advanced sorting and filters.

Loading calendar...

eFFECTOR Therapeutics (EFTR) Earnings Per Share

The chart below shows eFFECTOR Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q1	2024-05-09	$-2.16	$-2.16	0.00 %
Q4	2024-03-25	$-3.42	$-1.65	-107.3 %
Q3	2023-11-13	$-3.25	$-3.00	-8.33 %
Q2	2023-08-08	$-4.25	$-5.00	15.0 %

eFFECTOR Therapeutics (EFTR) Revenue

The chart below shows eFFECTOR Therapeutics's reported revenue compared to analyst estimates over recent quarters.

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q4	2023-03-08	$674.00K	$660.00K	2.12 %
Q3	2022-11-07	$867.00K	$640.00K	35.5 %
Q2	2022-08-09	$2.01M	$520.00K	286.7 %
Q1	2022-05-10	$0	$350.00K	-100.0 %

FAQ

When is eFFECTOR Therapeutics (OTCEM:EFTR) reporting earnings?

eFFECTOR Therapeutics (EFTR) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1.

What were the latest earnings per share (EPS) for eFFECTOR Therapeutics (OTCEM:EFTR)?

eFFECTOR Therapeutics (EFTR) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1 and the Actual EPS was $-2.16, which hit the estimate of $-2.16.

What were eFFECTOR Therapeutics’s (OTCEM:EFTR) revenues?

eFFECTOR Therapeutics (EFTR) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 9, 2024 for Q1 and the Actual Revenue was $0.00, which hit the estimate of $0.00.

eFFECTOR Therapeutics Earnings Estimates, EPS & Revenue | OTC:EFTR

In the most recent quarter (Q1), eFFECTOR Therapeutics reported EPS of $-2.16, meeting estimates of $-2.16. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, eFFECTOR Therapeutics has averaged an EPS surprise of 0.33% and a revenue surprise of 0.00%.

Earnings Date

May 9

EPS

$-2.160

Quarterly Revenue

$0.00

Annual Revenue
(as of Mar 31)

–